Kawasaki disease in Port Harcourt, Nigeria

Main Article Content

Woroma Wonodi
Tamunoiyowuna Grace Okari

Abstract

Kawasaki disease (KD) is an acute febrile vasculitis of childhood, predominantly affecting medium-sized arteries with a predilection for coronary arteries and commonly occurring in children under the age of 5 years. Early recognition can be challenging; however, delayed diagnosis increases the risk of coronary artery abnormalities and death. We report a case of KD in a 19-month-old child who presented with prolonged fever, conjunctival congestion, skin rash and redness of lips and tongue. He was initially managed as a case of complicated measles, but with worsening symptoms, KD was suspected. Echocardiography revealed a left coronary artery aneurysm. He received two doses of intravenous immunoglobulin G, over a period of 24 h and responded remarkably to treatment. KD is rare in Port Harcourt, Nigeria, and children with prolonged fever and erythematous rash may be mistakenly managed for measles if there is no high level of suspicion amongst clinicians.

Downloads

Download data is not yet available.

Article Details

How to Cite
Kawasaki disease in Port Harcourt, Nigeria. (2020). Port Harcourt Medical Journal, 14(3), 154-158. https://doi.org/10.60787/phmj.v14i3.166
Section
Case Report
Author Biography

Woroma Wonodi, Department of Paediatrics, Rivers State University Teaching Hospital

Department of Paediatrics and Child Health, Faculty of Clinical Sciences, College of Health Sciences, Rivers State University, Port Harcourt, Rivers State, Nigeria

References

1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long‑term management of Kawasaki disease: A scientific statement for health professionals from the American heart association. Circulation 2017;135:e927‑99.

2. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns CS, et al. Diagnosis, treatment and long‑term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation 2004;110:2747‑71.

3. Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, et al. Kawasaki disease: Guidelines of the Italian Society of Pediatrics, part I‑definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr 2018;44:102.

4. Lin MT, Wu MH. The global epidemiology of Kawasaki disease: Review and future perspectives. Glob Cardiol Sci Pract 2017;2017:e201720.

5. Animasahun BA, Madise‑Wobo AD, Kusimo OY. Nigerian children with acquired heart disease: The experience in Lagos. J Tehran Heart Cent 2017;12:160‑6.

6. Sadoh EW, Uzodimma CC, Daniels Q. Childhood acquired heart disease in Nigeria: An echocardiographic study from three centres. Afr Health Sci 2014;14:602‑8.

7. Animasahun BA, Akinola A, Adekunle MO, Gbelee HO. Kawasaki disease: Does it affect children in Lagos, Nigeria? J Cardiol Cardiovasc Ther 2016;1:555564.

8. Eno‑Obong EU, Mkpouto UA. Kawasaki disease in a two year old Nigerian child; full recovery with supportive treatment. Ibom Med J 2015; 8:18‑22.

9. Njama‑ Meya D, Clark TD, Nzarubara B, Staedke S, Kamya MR, Dorsey G. Treatment of malaria restricted to laboratory confirmed cases: A prospective cohort study in Ugandan children. Malar J 2007;6:7.

10. D’Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M, Genton B. Time to move from presumptive malaria treatment to laboratory‑confirmed diagnosis and treatment in African children with fever. PLoS Med 2009;6:e252.

11. West BA, Okari TG. Prevalence of malaria in febrile under five children in Port Harcourt, Nigeria. IOSR J Dental Med Sci 2018;17:46‑51.

12. MacFadden DR, Gold WL. Measles. Can Med Assoc J 2014;186:450.

13. Odei MO. Measles is in the news yet again. J Family Med Prim Care 2018;7:1166‑8.

14. Lo SF. Reference intervals for laboratory tests and procedures. In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, editors. Nelson Textbook of Pediatrics. 20th ed. Philadelphia: Elsevier Inc.; 2016. p. 3465‑70.

15. Animasahun BA, Adekunle MO, Kusimo OY, Fadipe C. The diagnosis of Kawasaki disease among Nigerian children: A nightmare for the caregivers and the doctors. J Public Health Emerg 2017;1:69.

16. Sani UM, Ahmed H. Kawasaki disease: An unusual presentation in a 14‑year old boy in Sokoto, North Western Nigeria. Niger J Paediatr2013;40:422‑5.

17. Ezeigho OR, Osuagwu MC, Ezike MN, Ibegbulem ZO, Kalu S. Malaria Parasitaemia in children aged 1‑5 years in Aba, South Eastern Nigeria. Int J Infect Dis 2014:1:1‑6.

18. Olasehinde GI, Ojurongbe DO, Akinjugunla OJ, Egwari LO, Adeyeba AO. Prevalence of malaria and predisposing factors to antimalarial drug resistance in South Western Nigeria. Res J Parasitol 2015;10:92‑101.

19. Church J, Maitland K. Invasive bacterial co‑infection in African children with Plasmodium falciparum malaria: A systematic review. BMC Med 2014;12:31.

20. Okunola PO, Ibadin MO, Ofovwe GE, Ukoh G. Co‑existence of urinary tract infection and malaria among children under five years old: A report from Benin City, Nigeria. Saudi J Kidney Dis Transpl 2012;23:629‑34.

21. Ibrahim BS, Usman R, Mohammed Y, Datti Z, Okunromade O, Abubakar AA, et al. Burden of measles in Nigeria: A five‑year review of case based surveillance data, 2012‑2016. Pan Afr Med J 2019;32 (Suppl 1):5.

22. Shorunke FO, Adeola‑Musa O, Usman A, Ameh C, Waziri E, Adebowale SA. Descriptive epidemiology of measles surveillance data, Osun state, Nigeria, 2016‑2018. BMC Public Health 2019;19:1636.

23. Rowley AH, Shulman ST. Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther 2010;8:197‑203.